ABOS: the balance sheet

MyFinsight

For the year ending 2025-12-31, ABOS has $122,833K in assets. $52,403K in debts. $53,989K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	53,989
Marketable securities, short-term	62,876
Prepaid expenses and other current assets	5,387
Total current assets	122,252
Marketable securities, long-term	0
Restricted cash	231
Other assets, long-term	350
Total assets	122,833

Accounts payable	554
Accrued clinical trial expenses	10,616
Accrued expenses and other current liabilities	10,072
Debt, short-term	8,765
Total current liabilities	30,007
Debt, long-term	22,396
Other liabilities, long-term	0
Total liabilities	52,403
Common stock, 0.0001 par value 300,000,000 shares authorized as of december31, 2025 and 2024 60,575,369 and 60,094,083 shares issued and outstanding as of december31, 2025 and 2024, respectively	6
Additional paid-in capital	516,803
Accumulated deficit	-446,462
Accumulated other comprehensive income (loss)	83
Total stockholders equity	70,430
Total liabilities and stockholders equity	122,833

Unit: Thousand (K) dollars (except for numbers of shares and EPS).